MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..

Alphagan (brimonidine)

Company: Allergan
Approval Status: Approved September 1996
Treatment for: open-angle glaucoma and ocular hypertension
Areas: Eye Health / Ophthalmology

| General Information | Mechanism of Action | Additional Information |

General Information

Alphagan has been approved for the treatment of open-angle glaucoma and ocular hypertension.

Mechanism of Action

Alphagan is a selective alpha-2 agonist, which significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. Its unique dual mechanism of action lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.

Additional Information

Glaucoma, an eye disease commonly characterized by excessive intraocular pressure, is a leading cause of blindness in the world.

< back to top

Alphagan Drug Information

The Alphagan drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2016 All rights reserved.